&) Citi Pharma Limited care to cure July 14, 2021 The General Manager, Pakistan Stock Exchange Limited, Stock Exchange Building, Stock Exchange Road, Karachi. subject: Material Information Dear sir, In accordance with Section 96 of Securities Act, 2015 and clause 5.6.1(a) of Code of Corporate Governance contained in the PSX Rule Book, rule we hereby convey the following information: Management of the Company is pleased to inform you the following: Contract Manufacturing Agreement M/s Citi Pharma Limited and CCL Pharma (Private) Limited have executed an agreement to manufacture Formulation Products on their behalf. This will lead to enhanced capacity utilization in the Company's Formulation segment Furthermore, this will lead to addition in the Company's profitabil years. yy and net margins over the next 2 to 3 You are requested to inform the members of the Exchange accordingly. Thanks and regards. Yours truly, for Citi Pharma Muhammad Riaz Company Secretary Cc: The Director/HOD, Surveillance, Supervision and Enforcement, SMD, SECP, islamabad The Executive Director, Corporate Supervision Department, SECP, Islamabad 588-0 Block MA Johar Town Lahore 042-35316587-20 24 Office Factory: 3 KM, Head Balok! Rosa, Bhai Pheru, Distt Kasur Pakistan Tel +92-40-4910160, +92-49-4519902 Fax: +92-49-4510101 email: info@citipharmaceuticals.com Website: www,citipharmaceuticals.com